NCDs are no longer your grandfather’s problem - and India’s young workforce is learning that the hard way

A 28-year-old software professional in Mumbai experienced chest pain radiating to the left arm. He was rushed to the emergency room and diagnosed with an anterior wall myocardial infarction, a full- blown heart attack. At twenty-eight.

This isn’t an isolated case. Data from hospitals across India shows that between 2020 and 2023, about half of heart attack patients were under 40. Indians tend to develop cardiovascular disease 5 to 10 years earlier than their Western counterparts, and 52% of deaths related to heart disease and stroke in India occur before age 70, compared to 23% in Western countries.

And hearts are simply the most dramatic aspect of the story. Type 2 diabetes, once a diagnosis typically associated with middle age, now frequently appears in people in their 20s and 30s. The ICMR-INDIAB study - the largest nationally representative diabetes survey India has ever conducted - found 101 million individuals with diabetes and 136 million with pre-diabetes, alongside 315 million suffering from hypertension. These aren’t projections. These are current figures.

The Lifestyle Mismatch

The risk factors are straightforward. India faces a mix of genetic, structural, and behavioural factors. The Indian body type is more susceptible to central obesity - abdominal fat - which directly leads to insulin resistance and cardiovascular disease. This is well-established epidemiology, not opinion. Add to that everyday reality: long sedentary work hours, processed food becoming the default, and stress that’s seen as a sign of professional dedication rather than a health risk.

Tobacco worsens the problem. According to India TB Report 2024, about 11% of TB patients screened in 2023 were tobacco users. In the wider population, the numbers are much higher. Research indicates 26% of cardiac diseases in the 30-44 age group are linked to tobacco use. Gutka, bidi, cigarette - the method of delivery varies, but the arterial damage remains the same. Poor sleep, irregular hours, and chronic stress complete the picture. Weekend outings mean buffets, stress relief means endless scrolling, and people only visit the doctor when it's already very late.

The Silent Epidemic in Plain Sight

NCDs now account for an estimated 66% of all deaths in India, according to the WHO’s NCD data portal. Cardiovascular disease alone is responsible for 27% of all deaths and 45% of deaths in the 40- 69 age group. India accounts for roughly one-fifth of global CVD deaths - disproportionate to its population share. The ICMR’s National Centre for Disease Informatics and Research (NCDIR) has projected that India is unlikely to meet the WHO’s “25x25” target of a 25% reduction in premature NCD mortality by 2025 compared to 2010 levels. The estimated reduction is closer to 13.9%.

Credit where it’s due: India was the first country in the world to adopt the WHO’s NCD Monitoring Framework in 2013, with 10 targets and 21 indicators. The government’s NPCDCS programme - recently rebranded as NPNCD - has expanded to over 524 district NCD cells, 565 NCD clinics, and 167 cardiac care units at district level. Population-based screening is being rolled out through 1.5 lakh Ayushman Arogya Mandirs. The India Hypertension Control Initiative has shown real results in states where it’s been implemented intensively.

But the gap between infrastructure and consistent delivery remains significant. Challenges include a shortage of trained screening personnel, low budget utilisation at the state level, inconsistent supply of essential NCD medicines, and weak follow-up systems. About 50-70% of NCD patients still seek treatment in the private sector, where costs are higher and quality varies. The infrastructure is being developed. However, the consistency needs to improve.

What Needs to Shift

First, discard the notion that NCDs are primarily a problem of wealthy urban areas. ICMR data is clear - rural India is rapidly catching up in the prevalence of diabetes, hypertension, and cardiovascular disease. While urban CVD prevalence is approximately 12% compared to 6% in rural regions, that rural figure is rising quickly as diets and lifestyles evolve. The epidemiological transition is no longer just an urban phenomenon.

Second, corporate India’s responsibilities extend far beyond annual health camps. While companies monitor quarterly revenue in real time, they lack insight into employee metabolic health. CSR investments could genuinely enhance community-level NCD prevention - through workplace screening programmes, subsidised diagnostics, and ongoing health literacy initiatives that are more meaningful than a poster in the canteen.

Third, promote health literacy early. By the time someone reaches 30 and is pre-diabetic, two decades of prevention opportunities have been missed. If a 15-year-old understands what metabolic syndrome is, what central obesity signifies, and why blood pressure is important - the 35-year-old version of that person is much less likely to end up in a cardiac ICU.

The harsh truth is this: India’s biggest health threat isn’t the next pandemic. It’s the slow, unnoticed build-up of lifestyle risks that only get attention when someone ends up in the ICU. There’s no lockdown for blocked arteries. No breaking news alert for rising HbA1c. But the figures don’t lie, and they’re urging us to act - now, not later.

For more information on this blog and or any other support, do contact YRGMERF on 044 33125000 and visit our website yrgmerf.org

#NCDIndia #HeartHealthIndia #DiabetesIndia #HypertensionIndia #YoungIndiaHealth #LifestyleDiseases #CardiovascularHealth #PreventiveHealth #PublicHealthIndia #HealthAwareness #WorkplaceHealth #StressAndHealth #SedentaryLifestyle #TobaccoControl #HealthPolicyIndia